In 2024, UAB "Caerus Biotechnologies" had revenue of 1 million EUR.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 1m € | 0 € | 0 € |
Profit | - | - +100.0% | -226,2k € -740.9% |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | -149,1k € | - +100.0% | -233,1k € |
Employees | - | - | - |
Overall rating | C+62/100 |
Financial health | 30/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 60/100 |
| Overall risk | Medium |
No risk flags | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Description | Registered |
|---|---|
| CEO (Male) |
UAB "Caerus Biotechnologies" is located at Vilnius, Mėnulio g. 11-101, LT-04326, LT-LT-04326.
The shareholders of UAB "Caerus Biotechnologies" include 1 Lithuanian legal entities. View ownership details →
Yes, UAB "Caerus Biotechnologies" is registered as an active VAT payer with VAT number LT100014166210.
UAB "Caerus Biotechnologies" was founded on June 22, 2021. The company has been operating for 5 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 5 years | 109 - 113 | 25% | |
Net revenue | 1 039 193,00 € | 12 - 16 | 91% | |
Equity | -149 094,00 € | - | 10% | |
Registered capital | 20 000,00 € | - | 90% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Registered in the Lithuanian register of legal entities.